These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21299899)

  • 41. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates.
    Hutin YJ; Hauri AM; Armstrong GL
    BMJ; 2003 Nov; 327(7423):1075. PubMed ID: 14604927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population risk of syringe reuse: estimating the probability of transmitting bloodborne disease.
    Sikora C; Chandran AU; Joffe AM; Johnson D; Johnson M
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):748-54. PubMed ID: 20509761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of need and supply of syringes for therapeutic injections in Pakistan.
    Khan AA; Saleem M; Qureshi H; Jooma R; Khan A
    J Pak Med Assoc; 2012 Nov; 62(11):1149-53. PubMed ID: 23866401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of autodisable syringe use and health care indicators are associated with high HIV prevalence: an international ecologic analysis.
    Deuchert E; Brody S
    Ann Epidemiol; 2007 Mar; 17(3):199-207. PubMed ID: 17174567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survey of syringe and needle safety among student registered nurse anesthetists: are we making any progress?
    Ford K
    AANA J; 2013 Feb; 81(1):37-42. PubMed ID: 23513322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reuse in sterile sites of single-use medical devices: how common is this in Australia?
    Collignon PJ; Graham E; Dreimanis DE
    Med J Aust; 1996 May; 164(9):533-6. PubMed ID: 8649288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential for medical transmission of HIV in Ethiopia.
    Priddy F; Tesfaye F; Mengistu Y; Rothenberg R; Fitzmaurice D; Mariam DH; del Rio C; Oli K; Worku A
    AIDS; 2005 Feb; 19(3):348-50. PubMed ID: 15718849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania.
    Hoelscher M; Riedner G; Hemed Y; Wagner HU; Korte R; von Sonnenburg F
    AIDS; 1994 Nov; 8(11):1609-15. PubMed ID: 7848599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sterilizable syringes: excessive risk or cost-effective option?
    Battersby A; Feilden R; Nelson C
    Bull World Health Organ; 1999; 77(10):812-9. PubMed ID: 10593029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injection safety: knowledge and practice among health workers.
    Ernest SK
    West Afr J Med; 2002; 21(1):70-3. PubMed ID: 12081351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.
    Reid S
    Indian J Community Med; 2012 Apr; 37(2):89-94. PubMed ID: 22654281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rapid assessment of safety injection in one county, north rural area in China].
    Yu HJ; Lei J; Luo HM; Wu HY; Ni DX; Song T; Xie SY; Li Q; Li Q; Ou JM; Zeng G; Li QL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):169-71. PubMed ID: 12816703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Syringe use and reuse: effects of syringe exchange programs in four cities.
    Heimer R; Khoshnood K; Bigg D; Guydish J; Junge B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S37-44. PubMed ID: 9663622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010.
    Pépin J; Abou Chakra CN; Pépin E; Nault V; Valiquette L
    PLoS One; 2014; 9(6):e99677. PubMed ID: 24911341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of SoloShot autodestruct syringes compared with disposable syringes, in a national immunization campaign in Indonesia.
    Nelson CM; Sutanto A; Suradana IG
    Bull World Health Organ; 1999; 77(1):29-33. PubMed ID: 10063658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early assessment of the implementation of a national programme for the prevention of mother-to-child transmission of HIV in Cameroon and the effects of staff training: a survey in 70 rural health care facilities.
    Labhardt ND; Manga E; Ndam M; Balo JR; Bischoff A; Stoll B
    Trop Med Int Health; 2009 Mar; 14(3):288-93. PubMed ID: 19187522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.
    Bartholomew TS; Feaster DJ; Patel H; Forrest DW; Tookes HE
    J Subst Abuse Treat; 2021 Aug; 127():108344. PubMed ID: 34134863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review.
    Reid SR
    Harm Reduct J; 2009 Aug; 6():24. PubMed ID: 19715601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.